Hepatitis B pre-S2 nucleic acid
First Claim
1. An isolated nucleic acid molecule encoding a middle Hepatitis B virus surface protein (MHB), wherein the nucleotide sequence of said molecule comprises a preS2 initiation sequence, wherein said preS2 initiation sequence starts with AAG or GAG nucleic acid sequence from the 5′
- end and before the initiation codon ATG of the preS2.
1 Assignment
0 Petitions
Accused Products
Abstract
This invention relates to a nucleic acid molecule encoding a middle Hepatitis B virus (HBV) surface protein, a vector comprising the nucleic acid molecule, a host cell comprising the vector, and a composition comprising the expression products of this vector, which may comprise middle HBV surface protein, or a mixture of middle HBV surface protein and small HBV surface protein. The compositions of the invention may be useful for expressing a middle HBV surface protein, or a mixture of small and middle HBV surface proteins in defined ratios, determining the binding of an antibody to a middle or small HBV surface protein, determining the quality of an anti-middle or an anti-small HBV surface protein antibody, or determining the quality of a kit containing anti-middle or anti-small HBV surface protein antibodies.
17 Citations
13 Claims
-
1. An isolated nucleic acid molecule encoding a middle Hepatitis B virus surface protein (MHB), wherein the nucleotide sequence of said molecule comprises a preS2 initiation sequence, wherein said preS2 initiation sequence starts with AAG or GAG nucleic acid sequence from the 5′
- end and before the initiation codon ATG of the preS2.
- View Dependent Claims (2, 3, 4, 5, 6, 11, 12)
-
7. A composition comprising isolated, recombinant MHB at a concentration of 1×
- 10−
12 to 1×
10−
2 gms. - View Dependent Claims (8, 9, 10, 13)
- 10−
Specification